The efficacy and safety of JNJ 39758979, a potent and selective H4R antagonist (Figure 3b and Figure 4b), were assessed by Kollmeier et al. in a study involving healthy subjects with histamine-induced pruritus. This evidence concerns the gene HRH4 and Pruritus.